?

Title Image

News

News

Material Information- (Supplemental Announcement of Material Information on August 6, 2026) Announcement of the newly appointed Chief Business Officer

2026-09-10

Material Information- The Company has been required by TPEx to announce the financial data according

2026-09-09

Material Information- Announcement of the Board’s Resolution to release the non-competition restriction on managerial officers

2026-09-07

Material Information- Announcement of the Board’s Resolution to Repurchase Treasury Shares

2026-09-07

Material Information- Announces on behalf of the subsidiary Handa Oncology, LLC, regarding FDA’s denial of the Citizen Petition against 505(b)(2) new drug HND-039 Omcazio

2026-09-04

Material Information- Announces on Behalf Handa Oncology, LLC, regarding the 505 (b)(2) new formulation drug HND-039 OMCAZIO receives U.S. FDA Final Approval (FA)

2026-09-04

Material Information- Regarding the 505(b)(2) new formulation drug HND-039 Omcazio patent infringement litigation has been voluntarily dismissed by the plaintiff

2026-08-28

Material Information- Announcement of the Completion of Registration for Capital Reduction through Cancellation of Treasury Shares

2026-08-27

Material Information- Announcement of the newly appointed Chief Business Officer

2026-08-06

Material Information- Announcement of the Board’s Resolution to release the non-competition restriction on managerial officers

2026-08-06

1
2
3
…
5
›